Distinct biogenesis pathways for human telomerase RNA and H/ACA small nucleolar RNAs

Molecular Cell

Volumn 11, Issue 5, 2003, Pages 1361-1372

  Fu, Dragony ^a   Collins, Kathleen ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN ACA; RNA; SMALL NUCLEAR RNA; TELOMERASE; UNCLASSIFIED DRUG;

ARTICLE; BIOGENESIS; CATALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSKERATOSIS CONGENITA; ENZYME INHIBITION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; PRECURSOR; PROTEIN MOTIF; PROTEIN PROCESSING; PROTEIN STABILITY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

EID: 0038392866     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(03)00196-5     Document Type: Article

References (43)

1. Antal M., Boros E., Solymosy F., Kiss T. Analysis of the structure of human telomerase RNA in vivo. Nucleic Acids Res. 30:2002;912-920.
2. Blackburn E.H. Switching and signaling at the telomere. Cell. 106:2001;661-673.
3. Bodnar A.G., Kim N.W., Effros R.B., Chiu C.-P. Mechanism of telomerase induction during T cell activation. Exp. Cell Res. 228:1996;58-64.
4. Chen J.-L., Blasco M.A., Greider C.W. Secondary structure of vertebrate telomerase RNA. Cell. 100:2000;503-514.
5. Chen J.-L., Opperman K.K., Greider C.W. A critical stem-loop structure in the CR4-CR5 domain of mammalian telomerase RNA. Nucleic Acids Res. 30:2002;592-597.
6. Chiu C.-P., Dragowska W., Kim K.W. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells. 14:1996;239-248.
7. Collins K., Mitchell J.R. Telomerase in the human organism. Oncogene. 21:2002;564-579.
8. Comolli L.R., Smirnov I., Xu L., Blackburn E.H., James T.L. A molecular switch underlies a human telomerase disease. Proc. Natl. Acad. Sci. USA. 99:2002;16998-17003.
9. Cuello P., Boyd D.C., Dye M.J., Proudfoot N.J., Murphy S. Transcription of the human U2 snRNA genes continues beyond the 3′ box in vivo. EMBO J. 18:1999;2867-2877.
10. Dokal I. Dyskeratosis congenita in all its forms. Br. J. Haematol. 110:2000;768-779.
11. Dragon F., Pogacic V., Filipowicz W. In vitro assembly of human H/ACA small nucleolar RNPs reveals unique features of U17 and telomerase RNAs. Mol. Cell. Biol. 20:2000;3037-3048.
12. Fatica A., Morlando M., Bozzoni I. Yeast snoRNA accumulation relies on a cleavage-dependent/polyadenylation-independent 3′-processing apparatus. EMBO J. 19:2000;6218-6229.
13. Feng J., Funk W.D., Wang S., Weinrich S.L., Avilion A.A., Chiu C., Adams R.R., Chang E., Allsopp R.C., Yu J.et al. The RNA component of human telomerase. Science. 269:1995;1236-1241.
14. Filipowicz W., Pogacic V. Biogenesis of small nucleolar ribonucleoproteins. Curr. Opin. Cell Biol. 14:2002;319-327.
15. Giorgi C., Fatica A., Nagel R., Bozzoni I. Release of U18 snoRNA from its host intron requires interaction of Nop1p with the Rnt1p endonuclease. EMBO J. 20:2001;6856-6865.
16. Härle-Bachor C., Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc. Natl. Acad. Sci. USA. 93:1996;6476-6481.
17. Hathcock K.S., Hemann M.T., Opperman K.K., Strong M.A., Greider C.W., Hodes R.J. Haploinsufficiency of mTR results in defects in telomere elongation. Proc. Natl. Acad. Sci. USA. 99:2002;3591-3596.
18. Heiss N.S., Knight S.W., Vulliamy T.J., Klauck S.M., Wiemann S., Mason P.J., Poustka A., Dokal I. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat. Genet. 19:1998;32-38.
19. Hernandez N., Lucito R. Elements required for transcription initiation of the human U2 snRNA gene coincide with elements required for snRNA 3′ end formation. EMBO J. 7:1988;3125-3134.
20. Hernandez N., Weiner A.M. Formation of the 3′ end of U1 snRNA requires compatible snRNA promoter elements. Cell. 47:1986;249-258.
21. Hirose T., Steitz J.A. Position within the host intron is critical for efficient processing of box C/D snoRNAs in mammalian cells. Proc. Natl. Acad. Sci. USA. 98:2001;12914-12919.
22. Kelleher C., Teixeira M.T., Forstemann K., Lingner J. Telomerase. biochemical considerations for enzyme and substrate Trends Biochem. Sci. 27:2002;572-579.
23. Kiss T. Small nucleolar RNAs. an abundant group of noncoding RNAs with diverse cellular functions Cell. 109:2002;145-148.
24. Kiss T., Filipowicz W. Exonucleolytic processing of small nucleolar RNAs from pre-mRNA introns. Genes Dev. 9:1995;1411-1424.
25. Kufel J., Allmang C., Chanfreau G., Petfalski E., Lafontaine D.L., Tollervey D. Precursors to the U3 small nucleolar RNA lack small nucleolar RNP proteins but are stabilized by La binding. Mol. Cell. Biol. 20:2000;5415-5424.
26. Mason P.J. Stem cells, telomerase and dyskeratosis congenita. Bioessays. 25:2003;126-133.
27. Martin-Rivera L., Blasco M.A. Identification of functional domains and dominant negative mutations in vertebrate telomerase RNA using an in vivo reconsitution system. J. Biol. Chem. 276:2001;5856-5865.
28. Mitchell J.R., Collins K. Human telomerase activation requires two independent interactions between telomerase RNA and telomerase reverse transcriptase in vivo and in vitro. Mol. Cell. 6:2000;361-371.
29. Mitchell J.R., Cheng J., Collins K. A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3′ end. Mol. Cell. Biol. 19:1999;567-576. a.
30. Mitchell J.R., Wood E., Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature. 402:1999;551-555. b.
31. Morlando M., Greco P., Dichtl B., Fatica A., Keller W., Bozzoni I. Functional analysis of yeast snoRNA and snRNA 3′-end formation mediated by uncoupling of cleavage and polyadenylation. Mol. Cell. Biol. 22:2002;1379-1389.
32. Neuman de Vegvar H.E., Lund E., Dahlberg J.E. 3′ end formation of U1 snRNA precursors is coupled to transcription from snRNA promoters. Cell. 47:1986;259-266.
33. Pogacic V., Dragon F., Filipowicz W. Human H/ACA small nucleolar RNPs and telomerase share evolutionarily conserved proteins NHP2 and NOP10. Mol. Cell. Biol. 20:2000;9028-9040.
34. Steinmetz E.J., Conrad N.K., Brow D.A., Corden J.L. RNA-binding protein Nrd1 directs poly(A)-independent 3′-end formation of RNA polymerase II transcripts. Nature. 413:2001;327-331.
35. Tesmer V.M., Ford L.P., Holt S.E., Frank B.C., Yi X., Aisner D.L., Ouellette M., Shay J.W., Wright W.E. Two inactive fragments of the integral RNA cooperate to assemble active telomerase with the human protein catalytic subunit (hTERT) in vitro. Mol. Cell. Biol. 19:1999;6207-6216.
36. Theimer C.A., Finger L.D., Trantirek L., Feigon J. Mutations linked to dyskeratosis congenita cause changes in the structural equilibrium in telomerase RNA. Proc. Natl. Acad. Sci. USA. 100:2003;449-454.
37. Verheggen C., Lafontaine D.L., Samarsky D., Mouaikel J., Blanchard J.M., Bordonne R., Bertrand E. Mammalian and yeast U3 snoRNPs are matured in specific and related nuclear compartments. EMBO J. 21:2002;2736-2745.
38. Vulliamy T.J., Marrone A., Goldman F., Dearlove A., Bessler M., Mason P.J., Dokal I. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature. 413:2001;432-435. a.
39. Vulliamy T.J., Knight S.W., Mason P.J., Dokal I. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol. Dis. 27:2001;353-357. b.
40. Vulliamy T.J., Marrone A., Dokal I., Mason P.J. Association between aplastic anemia and mutations in telomerase RNA. Lancet. 359:2002;2168-2170.
41. Wen J., Cong Y.S., Bacchetti S. Reconstitution of wild-type or mutant telomerase activity in telomerase-negative immortal human cells. Hum. Mol. Genet. 7:1998;1137-1141.
42. Wong J.M., Kusdra L., Collins K. Subnuclear shuttling of human telomerase induced by transformation and DNA damage. Nat. Cell Biol. 4:2002;731-736.
43. Zaug A., Lingner J., Cech T. Method for determining RNA 3′ ends and application to human telomerase RNA. NAR. 24:1996;532-533.